Journal article

Pre-Stroke CHADS(2) and CHA(2)DS(2) - VASc Scores Are Useful in Stratifying Three-Month Outcomes in Patients with and without Atrial Fibrillation

Hans TH Tu, Bruce CV Campbell, Atte Meretoja, Leonid Churilov, Kennedy R Lees, Geoffrey A Donnan, Stephen M Davis

Cerebrovascular Diseases | KARGER | Published : 2013

Grants

Funding Acknowledgements

Dr. Tu has received research funding from the Royal Melbourne Hospital Neuroscience Foundation. Dr. Campbell has received honoraria for speaking in educational symposia from Novartis and Boehringer Ingelheim and compensation for consultancy from H. Lundbeck A/S. Dr. Meretoja has received honoraria for speaking in educational symposia and compensation for consultancy with Boehringer Ingelheim, travel expenses from H. Lundbeck A/S and research funding from Sigrid Juselius and Biomedicum Helsinki Foundations. Dr. Churilov has received research funding from the Australian National Health and Medical Research Council, the Australian Commonwealth Scientific and Research Organization and is an editorial board member for Journal of Decision Systems, Operations Research for Health Care, Health Systems, Health Care Management Science, and International Journal of Stroke. Prof. Lees has received honoraria from Astellas, Asubio, Bayer, Boehringer Ingelheim, Johnson & Johnson, Lundbeck, Mitsubishi, Photothera, Sanofi- Aventis, Servier, Talecris, Wyeth, has held grant funding from the Chief Scientist Office of Scotland for a trial of AF, and serves as an editor for Stroke. Prof. Donnan has received research funding from the Australian National Health and Medical Research Council, the Australian Commonwealth Scientific and Research Organization and serves as an editorial board member for Stroke, Cerebrovascular Diseases, Journal of Clinical Neuroscience, and International Journal of Stroke